As healthcare costs rise and doctor shortages loom, local technology companies are ramping up development of software to make physicians and treatment more accessible to patients nationwide.
There’s not much ice in San Francisco, where I grew up, so hockey metaphors often go right over my head. But I can’t resist noting that Versant Ventures, led by a former hockey player, has made big line changes this decade... Read more »
The healthcare market continues to see a torrent of new apps, wearables, and medical devices, and digital health startup Validic is boosting its financial position to help healthcare providers connect with all this new technology.
The Durham, NC, company says it... Read more »
Seeking to bring together commerce tools and marketing capabilities in a single cloud-based software offering, NetSuite is acquiring marketing software company Bronto Software in a $200 million cash and stock deal.
The software platform of Bronto, a privately held Durham,... Read more »
Aerie Pharmaceuticals revealed this afternoon the first results from a group of late-stage trials for its glaucoma drug, and unfortunately for the Bedminster, NJ-based company, they don’t look pretty.
With the growing season well underway, Sam Brake’s attention is focused mainly on the fields where he sees North Carolina’s biofuel future.
The Department of Agriculture and North Carolina State University jointly run 18 agricultural research stations statewide that test various... Read more »
What are the forces shaping our innovation future—and who are the leaders who will build it? We can’t promise all the answers, but we can promise an unusually intimate and inspiring discussion of such questions at Xconomy’s most unique and exclusive... Read more »
Here are the week’s headlines in North Carolina biotech news:
—Scynexis (NASDAQ: SCYX) is raising $30 million through a secondary stock offering largely to finance clinical trials for its lead drug, an antifungal. The offering boosts the Durham, NC,... Read more »
Transforming big businesses into green businesses might seem like a thorny process.
A new MoneyTree Report being released today shows that U.S. venture capital activity eased off during the first three months of 2015. Yet it still marked the fifth consecutive quarter in which U.S. venture funding remained above $10 billion.
VCs invested... Read more »
[Updated 4/16/15, 10:56 am. See below.] Innocrin Pharmaceuticals is moving forward with a prostate cancer drug that it believes could better target the cancer while also causing fewer side effects compared to existing treatments. Now the company has some... Read more »
Most people who take prescription medication relate to the experience of occasionally missing a pill. For those who juggle multiple prescriptions, forgotten doses can become a regular occurrence.
Back in April 2011, at a biotech conference in San Francisco, a panel convened to discuss how hard it was to build biotech companies that could push through long, costly clinical trials before a drug comes to market. One panelist hedged... Read more »
Following a December surge, when U.S. venture firms invested $7.2 billion in 342 deals nationwide, VC activity reset at a lower pace during the first quarter of 2015, according to data being released today by CB Insights.
The New York venture... Read more »
[Corrected 4/14/14, 11:31 am. See below.] Borrowing money, or refinancing borrowed money, is easier now than it’s ever been as new online lenders put credit lines just a few clicks away. And now the traditional titans of Wall Street are... Read more »
The scientific revolution has ended. Or, at least it’s on pause, according to Roberta Ness, vice president of innovation at the University of Texas Health Science Center. She believes that science’s most promising thinkers aren’t taking big enough risks. They’re not... Read more »
In an annual spring ritual at the University of North Carolina at Chapel Hill, startup companies associated with the university get the opportunity for five minutes of stage time to present their technologies or products to a live audience. The UNC... Read more »
Here are the headlines from the last week in North Carolina biotech news.
—Pharmaceutical services provider Quintiles (NYSE: Q) is teaming up with lab testing company Quest Diagnostics (NYSE: DGX) to provide clinical trial laboratory services around the world.... Read more »
After five years of bootstrapping his startup, Instancy, Harvey Singh’s company has a finished education software product, revenue, and a growing roster of employees. As Singh looks overseas to expand Instancy’s sales reach, he says he is now ready for... Read more »
CoLucid Pharmaceuticals has barely finished unpacking after relocating to Massachusetts last week, but it has already pulled one thing out of its moving boxes—a document outlining plans for an initial public offering.
[Updated and corrected, 4/5/15, 6:51 pm. See below.] There is talk, and there is action. In the drive toward healthcare tailored for smaller and smaller groups of people, there was both last week, and both illustrated not just the... Read more »
Novan Therapeutics, which is researching applications of nitric oxide in treating skin conditions, has closed on $50 million in financing as the Durham, NC, moves its lead drug forward in clinical trials.
Peter Diamandis is, I think it’s fair to say, an optimist.
After all, how many other space-obsessed kids ended up founding an International Space University? Or inaugurated an XPRIZE, to inspire a new generation of passenger spacecrafts?
But Diamandis’s current obsession... Read more »
Energy savings that come from using networked devices make the concept of the “Internet of Things” an obvious cleantech play. But getting people to adopt these new systems might come down to the technology’s ability to adapt to, and perhaps improve... Read more »
Internet speeds are becoming increasingly important to consumer markets, as users of streaming content such as Netflix, Hulu, and HBO multiply. Those people are expecting quality streaming, too, especially with the advent of 4K, or “ultra” high-definition, video.
It may be... Read more »
Managing General Partner at Pappas Ventures
CEO and co-founder of BoostSuite
President of the Council for Economic Development (CED)
Retired CEO of ShopperTrak RCT Corporation
CEO of the Marine Bio-Technologies Center of Innovation
CEO of G1 Therapeutics
Vice Provost and Director of the Innovation and Entrepreneurship Initiative at Duke University
Managing Director of Hatteras Discovery and Venture Partner at Hatteras Venture Partners
President, CEO, and Chairman of the Board of SciQuest
Founder and CEO of Brooks Bell Inc.
Professor at the University of North Carolina at Chapel Hill